Meeting
2023 ASCO Genitourinary Cancers Symposium
European Association of Urology (EAU) Testicular Cancer Guidelines Panel: A new prognostic factor risk group classification for patients with clinical stage 1 seminoma in active surveillance.
Authors
Joost Boormans
UMC Rotterdam, Rotterdam, ON, Netherlands
Joost Boormans , Richard J Sylvester , Lynn Anson-Cartwright , Rachel Glicksman , Robert James Hamilton , Gedske Daugaard , Jakob Lauritsen , Thomas Wagner , Barbara Avuzzi , Nicola Nicolai , Jorge Aparicio , Xavier Garcia del Muro , Pilar Laguna
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral and Testicular Cancers
Track
Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 410)
DOI
10.1200/JCO.2023.41.6_suppl.410
Abstract #
410
Poster Bd #
D8
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
North American patterns of care in clinical stage I testicular cancer from SWOG S1823.
First Author: Antoine Morin Coulombe
Poster
2023 ASCO Annual Meeting
Prognostic factors for relapse in patients with clinical stage I testicular seminoma: A nationwide, population-based cohort study.
First Author: Thomas Wagner
Poster
2020 ASCO Quality Care Symposium
Testicular cancer management: Population-wide, rapid case ascertainment to drive early expert engagement and reduced practice variation.
First Author: Andrea Harzstark
Poster
2019 Genitourinary Cancers Symposium
Excellent outcomes in bilateral testicular germ cell tumors over four decades.
First Author: Ning-Ning Lu